Dr. Mingjiu Chen is the Founder and Chief Executive Officer of Biosion. He has 30+ years of broad experience in biomedical research, biologics R&D, and corporate operations as an entrepreneur.
Before founding Biosion, Dr. Chen worked in Abbvie, Lexicon Pharmaceuticals, SDIX and built strong expertise in therapeutics antibody discovery and biologics development. Dr. Chen has over 100 patent filings in therapeutic antibody field, over 10 innovative programs are currently in different stages of clinical trials.
Dr. Chen received his Ph.D. degree in Molecular Medicine from the University of Texas Health Science Center at San Antonio.